Allied Health & Imaging · Independent exam preparation
ARRT Cardiac Interventional Radiography (CI): Free Preparation Guide Study Guide
Practise contrast-reaction triage, radiation optimization, hemodynamic calculations, and device selection for ARRT Cardiac Interventional Radiography (CI).
By CertMedbry · Updated 14 October 2026
Learn to distinguish dangerous procedural changes from expected responses, choose imaging settings that preserve necessary detail, interpret cardiac measurements, and connect interventional devices with their mechanisms. This guide supports the ARRT Cardiac Interventional Radiography postprimary examination for certification and registration. Its 60 concepts are selective: the official examination content specifications define the full scope, including topics beyond this guide. Use the original cases, questions, and flashcards to practise explaining the decisive clinical or technical cue.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which certification and pathway does this guide address?
ARRT certification and registration in Cardiac Interventional Radiography, abbreviated CI, through the postprimary eligibility pathway. ARRT requires an existing credential in an approved supporting discipline, together with applicable education, ethics, clinical experience, and examination requirements. This is a radiologic technologist examination, not a nursing, nurse practitioner, or physician certification examination.
How are CI, VI, and the historical CV credential different?
CI and VI are separate ARRT disciplines with separate examination specifications. The legacy CV credential is Cardiovascular Interventional Radiography; ARRT no longer issues new CV credentials. The earlier combined name should not be substituted for the current CI examination or used to combine CI and VI preparation indiscriminately.
ARRT — R.T. Credential Options · ARRT — Reference Documents by Discipline
How many scored and unscored questions are specified?
The applicable outline specifies 145 scored questions plus 40 unscored pilot questions, for 185 questions altogether. The scored allocations are Patient Care 40, Image Production 20, and Procedures 85. Pilot questions are excluded when calculating the domain proportions used in this guide.
ARRT — Cardiac Interventional Radiography Examination Content Specifications
Which blueprint and effective date apply?
The examination content specifications were board approved in July 2022, implemented July 1, 2023, and marked V 2022.09.14. ARRT's October 2026 listings continue to identify this CI outline without a separately announced replacement. Check the issuer's discipline page for applicability to a later examination appointment; eligibility documents and examination specifications serve different purposes.
ARRT — Cardiac Interventional Radiography Examination Content Specifications · ARRT — Reference Documents by Discipline · ARRT — Examination Content Specifications
How should study time reflect the scored blueprint?
Calculated from the official scored counts, Patient Care accounts for approximately 27.59%, Image Production 13.79%, and Procedures 58.62%. Procedures contains 35 diagnostic/electrophysiology and 50 interventional questions. The guide allocates 17, 8, and 35 concepts respectively. Each 20-item practice format uses 6 Patient Care, 3 Image Production, and 11 Procedures items, approximating those proportions while preserving breadth.
ARRT — Cardiac Interventional Radiography Examination Content Specifications
What duration, delivery method, adaptivity, and item styles are verified?
The 2026 ARRT postprimary handbook lists 195 minutes of CI test time and a 215-minute appointment. The appointment includes the test and additional time for introductory and concluding activities; 215 minutes is not the question-answering allowance. Delivery is computer based at a Pearson test center. Most items are single-best-answer multiple choice. The handbook also describes possible multiple-response, ordering, image-selection, and video-based items. Question counts and random ordering do not establish whether a test is adaptive. This guide's four-option questions are independent single-best-answer learning drills and do not reproduce the examination interface.
Does CI certification establish permission to practise in every jurisdiction?
ARRT certification and registration identify a professional credential. They should not be treated as a universal licence or permission to perform every procedure independently. State or other jurisdictional requirements and employer-defined responsibilities are separate matters. This guide teaches the CI technologist knowledge assessed by the outline without asserting jurisdiction-specific consent rules or independent prescribing authority.
State Licensing - ARRT · postprimary-eligibility-pathway-handbook.pdf
This guide addresses CI technologist knowledge at entry level within ARRT's postprimary pathway. CI is separate from Vascular Interventional Radiography (VI) and the legacy Cardiovascular Interventional Radiography (CV) credential. These independently authored educational materials are not official ARRT examination items or a prediction of examination performance.
Outline used: ARRT Cardiac Interventional Radiography Examination Content Specifications: board approved July 2022; implemented July 1, 2023; document version V 2022.09.14. This remains the issuer-linked CI outline on 2026-10-09, Asia/Hong_Kong. The workbook label 'ARRT Certification in Cardiac Interventional Radiography (CI)' maps to this postprimary examination for certification and registration; the assigned slug is preserved.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Patient Care27.59% (40 of 145 scored questions)
1.When should an ad hoc PCI time-out occur?
A diagnostic angiogram can reveal findings that change the proposed procedure, its risks, and the equipment needed. Before elective ad hoc PCI, the team should reassess whether consent covers intervention, whether the anatomy warrants additional discussion, and whether physiology or other evaluation is needed. This pause connects the actual findings with the planned treatment. It also permits review of hemodynamic stability, contrast exposure, radiation burden, and available procedural resources before proceeding.
Apply it
During elective angiography, the operator identifies complex multivessel disease and considers immediate PCI. You identify that the documented discussion covered diagnostic catheterization only and communicate the need for an intervention-specific reassessment before equipment is opened.
Common pitfall: A completed preprocedure time-out does not automatically address newly discovered anatomy or an expanded treatment plan. Diagnostic consent should not be assumed to authorize every intervention.
2.Which contrast history most changes reaction planning?
A previous allergic-like reaction to the same contrast class is more informative than a nonspecific label such as iodine allergy. Establish the agent, symptoms, severity, timing, and treatment when possible. Hives, airway symptoms, and hypotension carry different implications from transient warmth or nausea. Shellfish allergy does not uniquely predict iodinated contrast reactions. A useful history supports a specific preparation plan rather than treating all reported allergies as interchangeable or assuming that premedication eliminates risk.
Apply it
One patient reports nausea during a prior injection; another describes diffuse hives and wheezing after iodinated contrast. You distinguish the histories and flag the second patient's previous allergic-like reaction for a targeted preparation and emergency-readiness discussion.
Common pitfall: The phrase iodine allergy obscures the actual reaction. Do not equate shellfish allergy, an antiseptic reaction, and a previous iodinated contrast reaction.
3.How do allergic-like and physiologic reactions differ?
Allergic-like contrast reactions resemble hypersensitivity, with findings such as urticaria, angioedema, or bronchospasm; they need not represent a proven IgE-mediated allergy. Physiologic reactions include effects such as warmth, nausea, and vasovagal changes. Classifying both mechanism and severity matters because a history of a physiologic reaction does not justify corticosteroid premedication for allergic-like reactions. During an event, progression and airway or circulatory involvement are more consequential than whether the patient has an allergy label.
Apply it
After contrast, a patient experiences brief warmth and a metallic taste without rash, dyspnea, or vital-sign change. You document the specific symptoms as a physiologic response rather than adding an unsupported allergic-like reaction label.
Common pitfall: Physiologic does not mean harmless: arrhythmia or severe hemodynamic disturbance can be physiologic. Conversely, mild hives are allergic-like even when vital signs remain stable.
4.Which cues distinguish vasovagal hypotension from anaphylaxis?
A vasovagal response commonly combines hypotension with bradycardia, pallor, diaphoresis, and a needle-related or anxiety-related trigger. Increased vagal activity slows nodal function and contributes to vasodilation. Anaphylactic shock more commonly combines hypotension with tachycardia and may include urticaria, airway edema, or bronchospasm. These are discriminating patterns, not absolute rules. Assess airway, breathing, circulation, and the whole presentation immediately; one heart-rate value cannot safely exclude a severe allergic-like reaction.
Apply it
During needle placement before contrast administration, a patient becomes pale and sweaty, with a pulse of 42/min and falling pressure. The timing and bradycardia support a vasovagal mechanism while the team promptly assesses and treats instability.
Common pitfall: Do not classify every episode of hypotension near contrast administration as anaphylaxis. Equally, absent hives or an atypical pulse does not exclude a serious reaction.
5.How should kidney risk be interpreted before contrast?
Kidney assessment should distinguish stable chronic impairment from acute kidney injury and consider the planned contrast route and overall clinical condition. A creatinine value is not a complete risk assessment, and an estimated filtration rate can be misleading when renal function is changing rapidly. Also distinguish contrast-associated kidney injury, which follows exposure, from contrast-induced injury, which implies causation. The practical decision is to identify genuine renal vulnerability and balance diagnostic benefit against avoidable exposure and competing clinical risks.
Apply it
A patient has a creatinine result similar to yesterday's but substantially above last week's baseline after hypotension. You flag the acute trend rather than interpreting a single automatically reported filtration estimate as proof of stable renal function.
Common pitfall: Do not attribute every postprocedure creatinine rise to contrast. Hemodynamic compromise and other causes may coexist, and one reassuring laboratory value can miss evolving injury.
6.When does contrast extravasation require urgent escalation?
Extravasation deposits contrast outside the vessel and may cause local inflammation or pressure-related injury. Stop the injection and obtain a clinical assessment of pain, swelling, sensation, perfusion, and movement. Increasing pain, sensory change, impaired capillary refill, reduced motion, or blistering raise concern for serious injury and warrant urgent evaluation. Severity is determined by the examination and progression, not a volume threshold alone. A small extravasation in a confined anatomical space can still threaten function.
Apply it
A wrist injection produces swelling followed by worsening pain, tingling, and painful finger movement. Even though the estimated extravasated volume is modest, you stop administration and communicate the progressive neurovascular findings for urgent assessment by the responsible clinician.
Common pitfall: Do not use estimated volume as the sole referral criterion. Initial comfort also does not guarantee a benign course because swelling and tissue injury may evolve.
7.Why are antiplatelets and anticoagulants not interchangeable?
Antiplatelet drugs reduce platelet activation or aggregation, whereas anticoagulants interfere with the coagulation process that generates fibrin. Both reduce thrombosis through different mechanisms and can increase bleeding. Aspirin or clopidogrel should therefore not be recorded as equivalent to warfarin or another anticoagulant. Before catheterization, identify the actual drug, recent administration, and intended role. The combination of therapies matters for procedural planning, but a generic blood thinner label cannot explain what protection or bleeding risk is present.
Apply it
A patient says they take a blood thinner. Medication reconciliation identifies clopidogrel but no oral anticoagulant. You document the specific antiplatelet medication and avoid reporting that the patient is already anticoagulated for every potential procedural purpose.
Common pitfall: Sharing the everyday label blood thinner does not imply identical action, monitoring, reversal, or indications. Neither class should be assumed to substitute for the other.
8.Why can normal oxygen saturation conceal hypoventilation?
Pulse oximetry estimates arterial oxygen saturation; it does not directly measure ventilation. Supplemental oxygen may preserve saturation while breathing slows and carbon dioxide accumulates. Exhaled carbon dioxide monitoring provides a more direct indication of ongoing ventilation, interpreted alongside respiratory effort and responsiveness. During sedation, a disappearing capnogram or declining respiratory activity requires assessment even when saturation remains normal. Check sampling problems as well as the patient, because a disconnected sampling line and true apnea can both remove the waveform.
Apply it
After sedation, an oxygen-supported patient's saturation remains 98%, but the capnogram disappears and chest movement stops. You immediately assess ventilation and airway patency rather than waiting for desaturation to establish that respiratory compromise has occurred.
Common pitfall: A normal saturation value is not evidence of adequate ventilation. Conversely, an absent capnogram needs clinical confirmation because sampling failure can mimic respiratory arrest.
9.How should electrical rhythm be linked to perfusion?
An ECG displays electrical activity; it does not establish effective circulation. In an unresponsive adult with absent or abnormal breathing, assess breathing and pulse simultaneously, taking no more than 10 seconds to check the pulse. If no definite pulse is felt, activate the emergency response and begin high-quality CPR immediately. Organized electrical activity without a pulse is pulseless electrical activity, a nonshockable arrest rhythm. CPR, prompt advanced resuscitation, and treatment of reversible causes are required; defibrillation is reserved for a shockable rhythm if one develops. These actions follow the AHA's current [Adult Basic Life Support](https://cpr.heart.org/en/resuscitation-science/cpr-and-ecc-guidelines/adult-basic-life-support) and [Adult Advanced Life Support](https://cpr.heart.org/en/resuscitation-science/cpr-and-ecc-guidelines/adult-advanced-life-support) guidance.
Apply it
An unresponsive patient has no normal breathing, an organized ECG, and no arterial pressure waveform. You activate the emergency response while checking for a pulse for no more than 10 seconds. With no definite pulse, you immediately begin high-quality CPR and identify suspected PEA; you do not deliver a shock solely because organized electrical activity is present.
Common pitfall: Do not prolong pulse assessment or delay compressions while waiting for another monitor to confirm arrest. An orderly ECG does not prove perfusion, and PEA is not treated by defibrillation.
10.What makes medication documentation clinically useful?
Medication documentation should identify the name, dose, administration site, route, and time. These details make it possible to reconstruct cumulative exposure and connect subsequent changes with an intervention. A statement such as sedation given does not distinguish drugs, repeated doses, or administration routes. Record associated observations and responses when relevant, especially during complications. Accurate timing supports safe handoffs by showing what has already been administered and when reassessment occurred, reducing the risk of unintended duplication or misleading attribution.
Apply it
During a long case, several small sedative doses are administered by different team members. You record each drug, amount, route, site, and time so the receiving clinician can assess cumulative exposure alongside the patient's current respiratory status.
Common pitfall: An end-of-case total cannot fully replace time-specific entries. Missing routes or times can make a plausible medication record unsafe to interpret during an emergency.
SCAI — Quality Documentation in the Cath Lab: Scope for Improvement
11.Which barriers are required for central venous insertion?
Central venous catheter insertion uses maximal sterile barrier precautions: a cap, mask, sterile gown, sterile gloves, and a sterile full-body drape. These barriers reduce opportunities for organisms to enter during a procedure that creates direct vascular access. A small fenestrated drape and gloves alone do not provide the same protection. Distinguish this requirement from less extensive precautions applicable to some peripheral catheter procedures. The device and insertion site determine the required barrier approach, rather than convenience or expected procedure duration.
Apply it
A central venous catheter tray is ready, but only a small drape and sterile gloves have been supplied. You identify the missing maximal barriers before insertion and help establish the complete sterile setup for the planned central access procedure.
Common pitfall: Do not generalize peripheral IV precautions to central access. Sterile gloves protect only part of the procedure and do not substitute for the complete barrier system.
CDC — Summary of Recommendations for Intravascular Catheter-Related Infections
12.Which skin preparation and drying steps does CDC recommend?
For central venous and peripheral arterial catheter insertion, CDC recommends a preparation containing greater than 0.5% chlorhexidine with alcohol. If chlorhexidine is contraindicated, tincture of iodine, an iodophor, or 70% alcohol can be used as alternatives. Apply the selected preparation correctly and allow it to dry according to the manufacturer's instructions before catheter placement. After preparation, avoid unprotected palpation that contaminates the site. Antiseptic selection, adequate drying, and maintained aseptic technique are complementary requirements.
Apply it
Before central access, you verify that the selected product contains greater than 0.5% chlorhexidine with alcohol. The prepared skin remains wet, so insertion waits until the manufacturer-directed drying step is complete. If chlorhexidine is contraindicated, the team selects one of the specified alternatives.
Common pitfall: Chlorhexidine concentration and the alcohol component both matter. Do not substitute an unspecified preparation, wipe it away to accelerate drying, or contaminate the prepared site through unprotected palpation.
CDC — Summary of Recommendations for Intravascular Catheter-Related Infections
13.How should contamination during a guidewire exchange be handled?
Aseptic technique depends on preventing contaminated hands or equipment from contacting the new intravascular device. CDC specifies new sterile gloves before handling a new catheter during guidewire exchange. If contamination occurs, identify the affected component and restore asepsis before it enters the vessel. An existing wire does not make an exchange exempt from infection precautions. Likewise, guidewire exchange is not a routine solution for a catheter suspected of infection, because the replacement can remain connected to a contaminated access pathway.
Apply it
During an exchange, a team member handles the removed catheter and then reaches for the replacement. You identify the need for new sterile gloves before the clean catheter is handled and communicate the contamination risk before insertion.
Common pitfall: Do not treat an exchange as inherently clean because no new puncture is planned. Previously worn gloves and an existing access tract can transmit contamination.
CDC — Summary of Recommendations for Intravascular Catheter-Related Infections
14.Which sharps-container features prevent handling injuries?
A suitable sharps container is closable, puncture resistant, and leak resistant on its sides and bottom. Safe disposal also depends on location and timely replacement: the container should be accessible where sharps are used and should not be filled beyond its designated limit. Once closed, it should remain closed for transport and disposal. The central decision is to eliminate extra handling of exposed sharps rather than moving, compressing, or transferring them to recover container capacity.
Apply it
The nearby sharps container has reached its marked fill line, and another used needle must be discarded. You obtain a replacement container instead of pushing down the contents or carrying the needle to an improvised waste receptacle.
Common pitfall: Do not reopen a sealed container or compress its contents. A rigid-looking waste bin is not automatically a puncture-resistant, leak-resistant sharps disposal container.
15.Why can a small acute effusion cause tamponade?
Tamponade occurs when pericardial pressure impairs cardiac filling and reduces effective output. The rate of fluid accumulation matters because the pericardium has less opportunity to accommodate rapidly added volume. Therefore, an acute procedural bleed can cause severe compromise despite an effusion smaller than a slowly developing chronic collection. New hypotension after an intracardiac procedure, particularly with rising venous pressure or an enlarging effusion, should prompt immediate communication and assessment rather than reassurance based on fluid size alone.
Apply it
After an ablation, a patient develops falling blood pressure while imaging shows a newly accumulating pericardial collection. You recognize that the rapid change is significant even though the collection appears smaller than a previously observed stable chronic effusion.
Common pitfall: Effusion size alone does not establish or exclude tamponade. Do not wait for a complete textbook cluster of physical signs before reporting acute deterioration.
16.What belongs in an access-site handoff?
An access-site handoff should connect the puncture location and hemostasis method with current observations and any complications. Describe the access technique, sheath or closure device, relevant medication exposure, and findings such as bleeding or altered distal perfusion. These details let the receiving team compare future changes with an established baseline. A dry dressing is only one observation, not a complete statement of procedural recovery. The handoff should identify what was done, what was observed, and what still requires surveillance.
Apply it
A patient leaves the laboratory after femoral access with a closure device and recent anticoagulant administration. You report the device, access location, current site appearance, distal findings, and any earlier bleeding rather than stating only that the procedure is complete.
Common pitfall: Successful device deployment does not prove that bleeding or vascular compromise cannot occur. A handoff that omits the hemostasis method makes subsequent assessment less informative.
SCAI — Quality Documentation in the Cath Lab: Scope for Improvement
17.Why should implant and complication records be traceable?
Procedural records should identify implanted devices and the equipment used, including relevant identifying information and lot numbers. This supports later interpretation of imaging, device follow-up, and investigation of a product concern. Complication documentation should describe what occurred and distinguish a procedural complication from the underlying disease process when that distinction is established. A traceable record links the final result to the actual intervention. Generic labels such as stent placed or patient unstable leave important questions unanswered for subsequent care.
Apply it
Two different stents are implanted during a case, followed by a treated procedural complication. You ensure that the device identifiers and the event's timing, observations, and management are recorded so follow-up clinicians can reconstruct the final procedural outcome.
Common pitfall: Do not substitute an inventory count for device identification or describe a complication with an unexplained label. Traceability and clinical interpretation require specific procedural information.
SCAI — Quality Documentation in the Cath Lab: Scope for Improvement
Image Production13.79% (20 of 145 scored questions)
18.How should pulse and acquisition rates be selected?
Fluoroscopy pulse rate and digital acquisition frame rate determine how often images are produced. Higher rates improve temporal sampling but can increase radiation exposure; the required rate depends on the motion and task being evaluated. Select the lowest rate that preserves necessary information, and keep acquisition runs appropriately short. Last image hold permits review of an already acquired image without continuing irradiation. It helps with static review but cannot show a device's new position after movement.
Apply it
The team pauses to review a stable catheter position after navigation. You use last image hold during discussion, then resume appropriate live imaging when movement begins, avoiding continuous irradiation solely to display an unchanged view during the pause.
Common pitfall: Do not reduce temporal sampling until critical movement becomes unreadable. Last image hold saves exposure during review but is not a substitute for current imaging during navigation.
IAEA — Radiation Protection of Patients During Interventional Cardiology · IAEA — Radiation Protection and Safety in Medical Uses of Ionizing Radiation, SSG-46
19.Why does collimation improve radiation efficiency?
Collimation restricts the irradiated field to the anatomy needed for the task. Excluding unnecessary tissue reduces the exposed area and can reduce scattered radiation reaching the detector and personnel. It therefore connects image quality and radiation protection rather than serving only as a cosmetic crop. Position the field so essential anatomy and device movement remain visible. Electronic cropping after acquisition changes presentation but does not undo exposure already delivered outside the displayed region during the acquisition.
Apply it
A coronary view includes a large area of irrelevant surrounding anatomy. You tighten collimation while retaining the target vessel and anticipated device movement, reducing unnecessary field exposure without compromising the information needed for the next procedural step.
Common pitfall: Postprocessing crop is not equivalent to beam collimation. Overly tight shutters can also hide a guidewire tip or complication outside the intended region of interest.
IAEA — Radiation Protection of Patients During Interventional Cardiology · IAEA — Radiation Protection and Safety in Medical Uses of Ionizing Radiation, SSG-46
20.When is acquisition magnification justified?
Acquisition magnification can help resolve small structures but commonly increases radiation requirements, so use the lowest magnification compatible with the clinical objective. Distinguish acquisition modes from enlarging a stored image: display zoom changes viewing size without adding new radiation, but it cannot recreate detail that was never captured. The decision should be tied to a specific visibility problem. If the necessary device or vessel detail is already clear, maintaining a wider usable field can avoid unnecessary exposure.
Apply it
A stored image clearly shows the required relationship between a stent and a side branch. You enlarge the existing display for discussion instead of obtaining another magnified acquisition merely to make the same visible finding larger.
Common pitfall: A larger displayed structure is not automatically more informative. Display zoom cannot restore missing spatial detail, while unnecessary acquisition magnification can increase radiation burden.
IAEA — Radiation Protection of Patients During Interventional Cardiology
21.How does imaging geometry affect entrance exposure?
Patient, tube, and detector positions influence image sharpness and radiation requirements. Keeping the detector close to the patient and avoiding an unnecessarily short tube-to-skin distance generally improves geometry. Steep angulation can increase the tissue thickness traversed by the beam, causing automatic exposure control to raise output. These relationships explain why an attractive projection can carry a substantial dose cost. Choose a clinically useful projection while considering patient clearance, detector proximity, and whether a less demanding angle supplies equivalent information.
Apply it
A steep oblique view produces a marked dose-rate increase without revealing additional anatomy needed for the task. The team selects a less demanding projection and brings the detector closer while maintaining safe clearance for the procedure.
Common pitfall: Do not assume identical fluoroscopy time means identical exposure across projections. Patient thickness, tube angle, and source-to-skin geometry can materially change the dose rate.
IAEA — Radiation Protection of Patients During Interventional Cardiology · IAEA — Radiation Protection and Safety in Medical Uses of Ionizing Radiation, SSG-46
22.Why does motion degrade a subtraction roadmap?
A subtraction roadmap relies on alignment between a reference image and subsequent images so background anatomy can be suppressed and the vascular path displayed. Patient movement, respiratory change, or equipment repositioning can break that alignment and create misleading residual structures. The practical clue is a roadmap that no longer matches current anatomy. Reassess the reference and imaging geometry instead of trying to navigate through an obviously misregistered display. Processing cannot reliably compensate for every major change in position.
Apply it
After the patient shifts, the roadmap shows doubled bony edges and the vessel overlay no longer aligns with the live device. You identify misregistration and communicate the need to restore alignment or obtain a suitable new reference.
Common pitfall: Do not interpret subtraction artifacts as new vascular findings or trust an old overlay after major motion. A visually persistent roadmap can still be anatomically inaccurate.
IAEA — Radiation Protection and Safety in Medical Uses of Ionizing Radiation, SSG-46
23.What determines safe power-injector compatibility?
A planned power injection must be compatible with the entire delivery pathway, including the catheter and connecting components. Verify manufacturer-specified pressure and flow limits rather than assuming every intravascular line tolerates mechanical injection. Patency assessment and appropriate preparation are also necessary; a pressure limit does not establish that the tip is correctly positioned or that extravasation cannot occur. Distinguish the requested flow from the equipment's allowable conditions and stop when the setup cannot support the planned injection safely.
Apply it
An injector is programmed for a rapid injection through a line whose power-injection rating is unknown. You verify the line and component limits before use instead of assuming that a functioning intravenous catheter is mechanically compatible.
Common pitfall: Do not treat a pressure alarm setting as proof of line safety. A lower setting cannot make an unverified catheter suitable or establish correct intravascular placement.
24.Which shielding placement best addresses staff scatter?
The patient is an important source of scattered radiation during fluoroscopy. Staff protection therefore requires shielding positioned between the scatter source and exposed body regions, alongside distance and controlled exposure time. Ceiling-suspended shields and table-side barriers complement protective garments when correctly placed. Their usefulness depends on geometry: a shield parked away from the scatter path offers limited protection. Review shield position when the projection or working position changes, and keep hands out of the primary beam rather than relying on garments.
Apply it
A projection change opens a gap between the patient and the ceiling-suspended shield near the operator's face. You reposition the barrier to intercept the scatter path while preserving access and visibility for the ongoing procedure.
Common pitfall: The presence of a shield does not prove effective protection. Poor placement, gaps, and hands in the primary beam can defeat an otherwise appropriate protective setup.
IAEA — Radiation Protection and Safety in Medical Uses of Ionizing Radiation, SSG-46
25.How do reference air kerma and kerma-area product differ?
Cumulative reference air kerma is the accumulated air kerma at the equipment's defined reference point, reported in Gy or mGy. Kerma-area product is air kerma integrated across the beam area, commonly reported in Gy·cm². Fluoroscopy time reports duration and does not incorporate all acquisition exposure or changing output. Neither dose indicator directly establishes peak skin dose: reference-point and skin locations differ, and table attenuation, backscatter, patient position, and projection affect skin exposure. Kerma-area product also does not identify where exposure was distributed; overlapping fields and separated fields can yield different local skin doses for the same total.
Apply it
Two procedures record the same kerma-area product, but one repeatedly uses a single entrance field while the other distributes exposure across several fields. Their peak skin doses can differ. You review cumulative reference air kerma, field overlap, geometry, and acquisition history rather than deriving an exact skin dose from either indicator alone.
Common pitfall: Gy and Gy·cm² describe different quantities. A higher kerma-area product does not by itself prove a higher peak skin dose. Reliable interpretation also requires equipment dose calibration and appropriate quality control, including protective-apron integrity assessment.
IAEA — Radiation Protection and Safety in Medical Uses of Ionizing Radiation, SSG-46
Procedures58.62% (85 of 145 scored questions)
26.How is stroke volume calculated from cardiac output?
Cardiac output is the volume delivered per minute, whereas stroke volume is the volume delivered per beat. The relationship is cardiac output equals heart rate multiplied by stroke volume, provided the measurements represent the same physiological state. Convert litres to millilitres when reporting millilitres per beat. The calculation also explains why an increased heart rate does not necessarily establish improved output: stroke volume may change simultaneously. Always retain units so a numerical answer can be checked for physiological and dimensional plausibility.
Apply it
A steady-state cardiac output is 4.8 L/min at 80 beats/min. Convert output to 4,800 mL/min and divide by 80 to obtain a stroke volume of 60 mL/beat, keeping the measurement times aligned.
Common pitfall: Multiplying output by heart rate reverses the relationship. Omitting the litre-to-millilitre conversion can produce a numerically correct-looking value with the wrong reported units.
27.How does the direct Fick calculation determine output?
The Fick principle relates oxygen uptake to blood flow and the arterial-minus-mixed-venous oxygen content difference. Cardiac output equals oxygen consumption divided by that content difference when the measurements are obtained under suitable steady-state conditions. Oxygen content is oxygen per volume of blood, not saturation alone. If consumption is expressed in mL oxygen/min and the difference in mL oxygen/dL blood, the result is dL blood/min and must be converted to L/min. Explicitly identify assumptions, including absence of a complicating shunt.
Apply it
With steady-state oxygen consumption of 250 mL/min and arterial and mixed-venous contents of 20 and 15 mL/dL, divide 250 by 5 to obtain 50 dL/min, then convert to a cardiac output of 5 L/min.
Common pitfall: Do not divide oxygen consumption by a saturation percentage difference or omit the decilitre conversion. Those errors substitute incompatible quantities for measured oxygen content.
28.Why must Fick samples represent the same state?
A Fick result combines oxygen consumption and arterial and mixed-venous oxygen contents as measurements of one physiological state. Changes in breathing, circulation, or intervention between measurements can make that combination internally inconsistent. Mixed-venous sampling should represent blood after systemic venous streams have mixed; an arbitrary peripheral venous sample is not equivalent. This is a measurement-quality issue before it is an arithmetic issue. A perfectly calculated quotient remains misleading if its inputs describe different moments or inappropriate sampling locations.
Apply it
Oxygen consumption is measured before a major hemodynamic change, but blood samples are collected afterward. You identify that combining the values would violate the intended steady-state comparison and request clarification before reporting the resulting calculated output.
Common pitfall: Do not label a peripheral venous sample mixed venous simply because it is venous. Correct arithmetic cannot repair mismatched timing or an unrepresentative sampling site.
29.How does ejection fraction differ from stroke volume?
Stroke volume is end-diastolic volume minus end-systolic volume. Ejection fraction divides that difference by end-diastolic volume and expresses the result as a proportion or percentage: EF = [(EDV − ESV)/EDV] × 100%. It therefore describes the fraction ejected, not the absolute volume delivered or total cardiac output. Two ventricles can have identical ejection fractions but different stroke volumes because their starting volumes differ. Interpret the measurement alongside ventricular size and clinical context rather than treating a percentage as a complete description of pumping performance.
Apply it
A ventricle has an end-diastolic volume of 120 mL and an end-systolic volume of 48 mL. Stroke volume is 72 mL, and ejection fraction is 72/120, or 60%; neither calculation alone supplies heart rate or output.
Common pitfall: Do not divide by end-systolic volume or equate a preserved ejection fraction with guaranteed normal output. Fractional emptying and absolute delivered volume answer different questions.
30.How do flow and gradient enter a simplified aortic valve-area estimate?
A transvalvular gradient depends on both valve obstruction and forward flow, so a small gradient during low flow does not exclude severe stenosis. The simplified Hakki estimate described in the ESC reference is AVA in cm² ≈ cardiac output in L/min divided by the square root of the mean transvalvular gradient in mmHg. For this method, use the time-averaged LV-to-aortic pressure difference during systolic ejection from appropriately acquired pressure data, not an arbitrary instantaneous difference or a substituted peak-to-peak gradient. It is an empirical approximation; rate, altered flow, regurgitation, shunts, and measurement error can limit interpretation.
Apply it
At a stable heart rate of 75/min, with no significant regurgitation or intracardiac shunt, measured forward output is 4.0 L/min and the mean systolic LV-to-aortic gradient is 25 mmHg. The simplified estimate is 4.0/√25 = 0.80 cm². The team interprets this estimate alongside valve imaging and flow conditions rather than using the gradient alone.
Common pitfall: Do not substitute a single pressure difference, mix measurements from different hemodynamic states, or assume every simplified valve formula uses the same gradient. The reference describes an additional rate-related adjustment above 90/min; that adjustment is outside this worked example.
The value of echocardiography in aortic valve disease: an in-depth analysis
31.How can oxygen samples suggest a left-to-right shunt?
A left-to-right shunt introduces oxygenated blood into the right-sided circulation. Sequential sampling can reveal an oxygen saturation or content increase where that additional blood enters. The location of the first convincing increase helps localize the communication, but sampling quality and mixing must be considered. One unusually high sample does not independently prove a shunt. Treat the pattern as physiological evidence requiring reliable site identification and corroboration, rather than assuming that all right-sided samples should have identical values. Shunt assessment and hemodynamic calculations are included in the official examination scope.
Apply it
A carefully labelled saturation run shows similar caval and right atrial values, followed by a reproducible increase in the right ventricle. You identify a ventricular-level step-up pattern for correlation with imaging rather than reporting an atrial-level communication.
Common pitfall: Do not localize a shunt from an unlabelled or isolated sample. Variable mixing, sampling position, and collection error can create apparent changes without a true communication.
ARRT — Cardiac Interventional Radiography Examination Content Specifications
32.What does fractional flow reserve measure?
Fractional flow reserve uses distal coronary pressure relative to aortic pressure during maximal hyperemia to assess the physiological effect of a stenosis. Reduced and relatively stable microvascular resistance makes pressure useful as a surrogate for flow limitation. This answers a different question from angiographic diameter narrowing: a visible lesion is not automatically physiologically significant. Valid interpretation requires an appropriate hyperemic state and reliable pressure measurements. The commonly used decision threshold is FFR at or below 0.80, interpreted with symptoms, anatomy, and the broader clinical context.
Apply it
An intermediate coronary narrowing has a distal pressure of 72 mmHg and an aortic pressure of 90 mmHg during adequate hyperemia. The pressure ratio is 0.80, meeting the commonly used FFR threshold for physiological significance. This supports clinical decision-making but does not by itself mandate PCI.
Common pitfall: Do not call a resting pressure ratio FFR or assume a visually intermediate lesion has a predictable physiological effect. Measurement conditions are part of the definition.
ACC — FFR/iFR: Are the Published Cutoffs Applicable in Athletes?
33.How do iFR and FFR conditions and thresholds differ?
Instantaneous wave-free ratio is measured during a defined resting diastolic interval without induced hyperemia; its commonly used decision threshold is at or below 0.89. FFR is measured during maximal hyperemia, with a threshold at or below 0.80. The indices and thresholds are not interchangeable. The [2021 ACC/AHA/SCAI Coronary Artery Revascularization Guideline](https://www.heart.org/-/media/PHD-Files-2/Science-News/2/2021/2021-Coronary-Artery-Revascularization-Guideline-Slide-Set.pdf) advises against PCI in stable patients with angiographically intermediate stenoses when FFR exceeds 0.80 or iFR exceeds 0.89. Meeting a threshold supports assessment of physiological significance; it does not alone establish that intervention is appropriate.
Apply it
A stable patient with an intermediate lesion has a technically valid resting iFR of 0.92. This exceeds 0.89 and does not support PCI for that lesion on this physiological assessment. An iFR of 0.88 would meet the usual threshold, prompting integration with symptoms, anatomy, and treatment goals rather than automatic intervention.
Common pitfall: Do not apply the FFR threshold to iFR or relabel every pressure-wire result as FFR. Borderline values and discordant findings require attention to measurement quality and clinical context.
ACC — FFR/iFR: Are the Published Cutoffs Applicable in Athletes?
34.Which questions do IVUS and OCT answer?
Intravascular ultrasound and optical coherence tomography provide cross-sectional information that a projected angiographic lumen cannot fully supply. IVUS uses ultrasound; OCT uses light and offers detailed superficial structural information. Their images can help characterize calcium and assess stent expansion or apposition. Calcium thickness assessment is particularly useful with OCT when adequately visualized. Choose the technique around the anatomical question and acquisition requirements. Neither modality directly substitutes for a coronary physiological measurement simply because it reveals a detailed lesion.
Apply it
A stent looks satisfactory on angiography, but the operator questions expansion within a calcified segment. You prepare the requested intravascular imaging system to examine cross-sectional structure rather than assuming the projected lumen proves adequate expansion throughout.
Common pitfall: Do not confuse detailed anatomy with demonstrated flow significance. Also distinguish expansion from apposition: a stent can contact the wall yet remain inadequately expanded.
SCAI Expert Consensus Statement on the Management of Calcified Coronary Lesions — SOLACI-hosted full text · SCAI — Expert Consensus Statement on Management of In-Stent Restenosis and Stent Thrombosis
35.Why is echocardiography useful during intracardiac procedures?
Echocardiography supplies information about soft-tissue anatomy, motion, and fluid that fluoroscopy alone may not provide. Intracardiac echocardiography places an ultrasound transducer within the heart to support procedural assessment; other echocardiographic approaches may be selected for particular procedures. The useful distinction is complementary information rather than a universally superior modality. During catheter manipulation or structural intervention, echocardiographic findings can help connect device position with tissue relationships and identify a developing pericardial collection when acute hemodynamic changes occur.
Apply it
During an intracardiac procedure, fluoroscopy shows the device but a new pressure decline raises concern for an effusion. You support prompt echocardiographic assessment because the clinical question concerns fluid and tissue effects beyond the visible radiopaque equipment.
Common pitfall: Do not infer absence of a pericardial collection from a satisfactory fluoroscopic device image. Conversely, echocardiography does not eliminate the need for appropriate device-position imaging.
ESC — Cardiac Tamponade: A Clinical Challenge · FDA — MitraClip Summary of Safety and Effectiveness Data
36.How does electrophysiologic mapping guide treatment?
Electrophysiologic mapping uses recorded electrical signals and their timing to identify tissue involved in an arrhythmia. The goal is to locate an abnormal source or pathway so treatment can be directed to a meaningful target. Fluoroscopy shows catheter position but does not independently identify the tissue's electrical role. Mapping therefore links anatomy with function. A visible catheter at a plausible anatomical location is insufficient by itself to justify ablation; the electrical findings must support the intended target.
Apply it
Several catheters are positioned during an arrhythmia study, and the operator compares local signals before choosing an ablation site. You recognize that the signal timing identifies the functional target while imaging confirms where the recording catheter is located.
Common pitfall: Do not equate catheter visibility with successful mapping. An anatomically plausible site may not participate in the arrhythmia, and treatment requires electrical as well as positional information.
37.Why does radiofrequency ablation alter an arrhythmia pathway?
Radiofrequency ablation delivers energy to create a localized tissue lesion at a selected electrical target. Interrupting abnormal conduction or eliminating an arrhythmogenic focus can prevent the pathway from sustaining the rhythm disturbance. It differs from delivering an electrical shock to terminate a current arrhythmia: ablation changes the tissue substrate. Precise targeting is essential because nearby tissue may have an important normal electrical function. Procedural assessment therefore combines catheter location, electrical mapping, and the effect of the applied treatment.
Apply it
A recurrent tachyarrhythmia is mapped to a specific abnormal pathway. You explain that the planned radiofrequency treatment seeks to interrupt that pathway, whereas cardioversion would primarily terminate the present rhythm without creating the same targeted tissue lesion.
Common pitfall: Do not describe ablation as a stronger cardioversion shock. Rhythm termination and modification of the arrhythmia substrate are different mechanisms and different procedural objectives.
38.How are pacing capture and sensing different?
Pacing capture means a delivered stimulus produces the intended myocardial depolarization. Sensing means the device detects intrinsic electrical activity so it can respond according to its programmed function. A pacing spike without the expected subsequent depolarization suggests failure to capture; inappropriate spikes despite intrinsic activity suggest a different sensing problem. These concepts are distinct from the patient's mechanical response. After identifying electrical capture, correlate it with pulse and pressure rather than assuming that every paced electrical event guarantees adequate perfusion. Pacing and implanted rhythm devices are included in the examination outline.
Apply it
A temporary pacing trace shows repeated stimulus spikes without corresponding ventricular complexes. You identify an electrical capture problem and communicate the pattern, while also reporting the patient's pulse and pressure rather than describing the issue simply as an irregular rhythm.
Common pitfall: Do not call every pacing abnormality failure to sense. Capture concerns the response to a delivered stimulus; sensing concerns recognition of the patient's own electrical activity.
ARRT — Cardiac Interventional Radiography Examination Content Specifications · AHA — Surgical Procedures for Atrial Fibrillation
39.Which function distinguishes an ICD from a pacemaker?
A pacemaker supplies electrical stimulation when appropriate to support heart rate or coordinated activation. An implantable cardioverter-defibrillator detects specified dangerous ventricular rhythms and can deliver therapy to terminate them. Some ICDs also provide pacing, so the distinction concerns capability rather than mutually exclusive boxes. Identify the intended device function before preparing equipment or interpreting follow-up instructions. A device described only as implanted near the clavicle cannot be classified reliably without knowing its purpose and system characteristics.
Apply it
A device is planned for a patient at risk of life-threatening ventricular tachyarrhythmia, and the team describes automatic detection and shock capability. You identify an ICD function even though the system can also provide pacing support.
Common pitfall: Do not assume every implanted rhythm device is a pacemaker or that an ICD lacks pacing. Shared appearance or implantation location does not establish identical function.
40.How does ultrasound improve radial access assessment?
Ultrasound allows direct assessment of radial vessel location and diameter and supports visualization during access. Its benefit is particularly clear when pulse palpation does not adequately describe the anatomy. SCAI reports improved first-pass success and fewer attempts with ultrasound-guided radial access. Fewer punctures reduce opportunities for arterial wall trauma, but that observation should not be converted into a claim that ultrasound alone eliminates radial occlusion. Access assessment, equipment sizing, anticoagulation, and hemostasis remain distinct contributors to a successful procedure.
Apply it
A patient's radial pulse is palpable, but previous access attempts were difficult. Ultrasound reveals a small vessel and clarifies its course, allowing the operator to plan puncture and equipment around the actual anatomy rather than pulse strength alone.
Common pitfall: A palpable pulse does not establish vessel diameter or guarantee easy access. Ultrasound guidance improves access information but does not replace subsequent measures to preserve patency.
SCAI — Radial Artery Occlusion After Transradial Cardiac Catheterization
41.Why does sheath-to-artery size matter?
A sheath that occupies a large proportion of the radial artery can impede flow and increase vessel injury risk. The relevant comparison is the sheath's outer diameter against the artery's internal diameter, not the nominal device label alone. Different sheath designs can have different external dimensions despite accommodating similar catheters. Assess the access vessel and choose an appropriate system for the procedural requirement. Smaller compatible equipment can reduce mismatch, but it must still support the devices needed for the planned intervention.
Apply it
Ultrasound identifies a small radial artery. Before selecting between two systems that accept similar catheters, the team compares their actual sheath outer diameters and chooses equipment that satisfies procedural needs with less access-vessel mismatch.
Common pitfall: Do not compare artery size only with catheter diameter or assume matching nominal French labels guarantee matching outer dimensions. The component occupying the artery matters.
SCAI — Radial Artery Occlusion After Transradial Cardiac Catheterization
42.What makes radial hemostasis patent?
Patent hemostasis controls puncture-site bleeding while preserving antegrade radial arterial flow. Excessive compression may achieve a dry site by stopping flow, creating conditions that favor occlusion. The target is therefore adequate hemostasis with demonstrated patency, using an appropriate assessment rather than appearance alone. A warm hand can remain perfused through collateral circulation even when radial flow is absent. Assess the artery specifically and follow the intended compression protocol rather than assuming that more pressure always means better recovery.
Apply it
After radial catheterization, the access site is dry but flow assessment shows loss of radial patency. Compression is carefully adjusted within the hemostasis protocol to restore forward flow while confirming that puncture-site bleeding remains controlled during observation.
Common pitfall: A dry dressing or warm hand does not independently prove radial patency. Do not maximize compression simply because complete arterial occlusion appears to stop bleeding reliably.
SCAI — Radial Artery Occlusion After Transradial Cardiac Catheterization
43.How does balloon angioplasty differ from stenting?
Balloon angioplasty enlarges a narrowed lumen by applying radial force to the lesion. A stent provides a scaffold that remains after the delivery balloon is removed. This distinction explains why balloon expansion, residual narrowing, recoil, and tissue injury matter to the next procedural decision. A balloon that crosses a lesion is not necessarily able to expand it adequately, particularly when calcium constrains the vessel. Assess the response to preparation rather than treating device delivery as proof of successful lesion modification.
Apply it
A balloon reaches the target coronary segment but retains a pronounced waist during inflation. You recognize that crossing success has not established adequate lesion expansion and prepare for further assessment of the resistant segment before the planned stent is deployed.
Common pitfall: Do not confuse a deliverable balloon with a dilatable lesion. Increasing pressure without understanding resistance can create injury while leaving an important calcium-related constraint unresolved.
44.Why can calcium prevent adequate stent expansion?
Rigid coronary calcium can resist balloon expansion and constrain the deployed stent. Its arc, thickness, length, and distribution influence how the lesion responds to preparation. Intravascular imaging helps define these features more specifically than a projected angiogram alone. The procedural objective is sufficient lesion modification to permit effective expansion, not merely successful stent delivery. A small final cross-sectional area can persist despite an apparently acceptable angiographic appearance, which is why structural assessment matters when resistant calcium is suspected.
Apply it
A calcified lesion allows stent delivery, but cross-sectional imaging shows a tightly constrained segment. You recognize the mechanical expansion problem and distinguish it from a device-position issue, supporting the operator's assessment of the underlying calcium before additional treatment.
Common pitfall: Wall contact does not prove adequate expansion. A stent can be apposed yet constrained, and a satisfactory projected lumen can conceal an unfavorable cross-sectional result.
45.How should recurrent stent failure be investigated?
Stent failure requires a mechanism-based assessment. Intracoronary imaging can distinguish underexpansion, in which the scaffold itself has an inadequate area, from neointimal hyperplasia, in which tissue grows inside the scaffold and narrows the lumen. Neoatherosclerosis involves atherosclerotic change within neointimal tissue, such as lipid accumulation or calcification. Thrombus is intraluminal clot and may coexist with other mechanisms. Timing helps frame the possibilities but does not replace imaging. SCAI emphasizes identifying the cause before selecting treatment, because adding another stent can leave an underlying expansion problem unresolved.
Apply it
OCT shows a small stent area constrained by surrounding calcium, with little tissue inside the scaffold. This supports underexpansion. Abundant tissue inside a sufficiently expanded scaffold would instead support a tissue-related mechanism, while lipid-rich neointima or an intraluminal thrombotic mass would suggest different processes.
Common pitfall: Do not equate every small lumen with neointimal hyperplasia. Compare the lumen with the scaffold dimensions and characterize the tissue; underexpansion and malapposition are also distinct findings.
SCAI — Expert Consensus Statement on Management of In-Stent Restenosis and Stent Thrombosis · SCAI Expert Consensus Statement on the Management of Calcified Coronary Lesions — SOLACI-hosted full text
46.How does intravascular lithotripsy modify calcium?
Intravascular lithotripsy delivers pressure waves from emitters within a balloon catheter to fracture vascular calcium and improve lesion compliance. Its defining mechanism differs from using a rotating abrasive burr to modify plaque. Because the balloon-based system must reach the target, deliverability is a practical boundary: a balloon-uncrossable lesion presents a different problem from a balloon-crossable but poorly expandable lesion. The goal is calcium modification that supports subsequent expansion, not removal of all plaque or substitution for the final scaffold when one is required.
Apply it
A balloon can cross a calcified segment but expands poorly, and imaging shows circumferential calcium. The team considers a balloon-based pressure-wave treatment to improve compliance, distinguishing that objective from the need to create passage through an uncrossable lesion.
Common pitfall: Do not describe lithotripsy as rotational plaque abrasion. Also, a suitable calcium pattern does not guarantee deliverability of the balloon catheter to the intended segment.
47.What distinguishes rotational atherectomy?
Rotational atherectomy uses a rapidly rotating, diamond-coated burr to modify resistant plaque, especially superficial calcified tissue, over a dedicated guidewire system. It is mechanically different from ordinary balloon expansion and from balloon-based lithotripsy. The equipment and wire requirements are therefore part of the procedure, not interchangeable accessories. Recognize the intended lesion-preparation role and the need for careful operation in a vessel where abrasive treatment can produce complications. Successful modification should be assessed before assuming that subsequent devices will expand appropriately.
Apply it
The operator selects rotational atherectomy for a resistant calcified lesion. You prepare the dedicated burr and compatible wire system rather than substituting a standard balloon setup, and anticipate reassessment of lesion response before the planned stent deployment.
Common pitfall: Do not assume every coronary guidewire is compatible with a rotational burr. Atherectomy modifies plaque; it does not itself establish that the final stent result will be adequate.
48.How do orbital and laser atherectomy differ?
Orbital atherectomy uses an eccentrically mounted abrasive crown whose orbital motion modifies calcified tissue. Excimer laser coronary atherectomy instead uses ultraviolet energy with photochemical, acoustic, and cavitation effects on tissue. These mechanisms require different consoles, catheter systems, and operating conditions. The word atherectomy therefore does not describe one interchangeable equipment set. Distinguish the requested modality before preparing the system, and recognize that imaging-defined lesion characteristics and device deliverability influence which type of modification is technically appropriate.
Apply it
A case booking lists atherectomy, but the operator specifies excimer laser when the lesion is reviewed. You clarify the requested modality and prepare the laser catheter and console rather than opening an orbital crown system based on the broad label.
Common pitfall: Do not treat rotational, orbital, and laser devices as equivalent accessories. Their energy delivery, wire compatibility, and preparation requirements differ despite their shared lesion-modification purpose.
49.Why are thrombectomy and embolic protection different?
Thrombectomy removes or disrupts thrombotic material at a target, while distal embolic protection seeks to intercept material that could travel downstream during intervention. Their objectives overlap in protecting flow but their mechanisms and device locations differ. An embolic protection device does not establish that the original lesion has been treated, and removing thrombus does not eliminate every opportunity for downstream embolization. For equipment planning, identify whether the requested device treats the source material, protects a distal territory, or serves another procedural function. These procedures are part of the official examination scope.
Apply it
During a planned intervention, the operator requests both a thrombus-removal device and distal protection. You recognize two separate functions and prepare the systems accordingly, rather than assuming that one device makes the other request redundant or interchangeable.
Common pitfall: Do not infer a universal indication from a device's mechanism. Understanding removal versus downstream protection does not establish that either technique is appropriate for every lesion.
ARRT — Cardiac Interventional Radiography Examination Content Specifications
50.When should an intra-aortic balloon inflate and deflate?
An intra-aortic balloon pump uses counterpulsation: inflation occurs at the onset of diastole, after aortic valve closure, and deflation occurs before systolic ejection. Diastolic inflation augments aortic pressure, while timely deflation reduces resistance to ventricular ejection. Correct timing therefore connects the device's two intended effects to separate phases of the cardiac cycle. Review the arterial waveform and trigger quality when augmentation changes. Inflation extending into ejection can oppose the ventricle rather than provide the intended unloading effect.
Apply it
The assisted waveform shows balloon inflation beginning before aortic valve closure. You identify early inflation as a timing concern and communicate it for correction rather than interpreting any increased aortic pressure as evidence of beneficial counterpulsation throughout the cycle.
Common pitfall: Do not reverse inflation and deflation phases or rely on augmentation height alone. Correct timing relative to valve closure and ejection determines the physiological effect.
51.Why is aortic regurgitation important for IABP physiology?
Aortic regurgitation permits diastolic flow from the aorta back into the left ventricle. Increasing aortic diastolic pressure through balloon inflation can therefore increase the pressure driving backward flow. This explains the important concern with more than mild regurgitation in traditional IABP use. The mechanism differs from simply having low blood pressure or poor ventricular contraction. Recognizing the valve lesion matters because an intervention intended to improve diastolic coronary perfusion can simultaneously worsen regurgitant loading of the ventricle.
Apply it
Before an IABP setup, the team identifies significant aortic regurgitation on recent imaging. You flag the valve finding because balloon-generated diastolic pressure could increase backward flow, requiring reassessment of the intended support mechanism by the treating team.
Common pitfall: Do not assume diastolic augmentation benefits every valve condition. In regurgitation, raising aortic diastolic pressure may increase ventricular volume loading rather than simply improve perfusion.
52.How does a transvalvular left ventricular pump support flow?
A transvalvular microaxial left ventricular support pump draws blood from the left ventricle and delivers it into the ascending aorta. This provides forward flow while reducing ventricular loading, unlike IABP counterpulsation, which displaces aortic blood in relation to the native cycle. Inlet and outlet positions are central to the mechanism. A device can be present yet provide ineffective support if its relationship to the ventricle and aorta is incorrect. Understand this flow path without treating historical device comparisons as current selection rules.
Apply it
The team reviews a support catheter whose inlet should lie in the left ventricle and outlet in the aorta. You identify why position assessment matters: the intended flow pathway depends on straddling the valve in the correct relationship.
Common pitfall: Do not describe a microaxial pump as an IABP or assume insertion proves effective support. Different flow mechanisms create different positioning requirements and physiological consequences.
53.What distinguishes VA-ECMO from isolated ventricular support?
Venoarterial extracorporeal membrane oxygenation drains venous blood, passes it through a pump and membrane oxygenator, and returns it to the arterial circulation. It therefore combines circulatory support with extracorporeal gas exchange. An isolated ventricular pump does not automatically provide oxygenation simply because it increases flow. The arterial return also changes cardiovascular loading, so oxygenator function and flow support are related but separate assessments. Identify the drainage and return sites when explaining the circuit rather than using ECMO as an undifferentiated label.
Apply it
A proposed circuit drains systemic venous blood, uses a membrane oxygenator, and returns oxygenated blood through an arterial cannula. You identify VA-ECMO and distinguish its gas-exchange component from the operation of an isolated left ventricular support pump.
Common pitfall: Do not assume every ECMO configuration provides the same circulatory support. Venous versus arterial return changes the circuit's role, and forward flow alone does not establish gas exchange.
54.Why does large-bore access require distal perfusion surveillance?
A large arterial sheath or cannula can compromise flow in an access vessel and may coexist with vascular injury or thromboembolism. Distal limb assessment is therefore a physiological check on the access pathway, not merely a dressing inspection. Compare perfusion findings with the baseline and communicate new abnormalities promptly. Peripheral arterial disease increases the importance of understanding vessel suitability. The absence of visible puncture-site bleeding does not establish that blood is reaching the distal territory adequately while the device remains in place.
Apply it
A patient with femoral mechanical-support access develops a cooler foot and weaker distal Doppler signal than before placement. You promptly report the change as a possible access-related perfusion problem even though the groin dressing remains dry.
Common pitfall: Do not equate a clean access site with normal distal circulation. Large-bore devices can impair limb perfusion without producing an obvious external hematoma or dressing change.
55.How does pericardiocentesis relieve tamponade?
Pericardiocentesis removes fluid from the pericardial space, lowering the external pressure that restricts cardiac filling. Its target is the pericardial collection, not a cardiac chamber or pleural effusion. When tamponade is present, improving filling can improve output even after removal of a relatively small amount of fluid because the pressure-volume relationship is steep. Imaging helps identify the collection and guide access. The procedure's rationale depends on hemodynamic impact, not simply the presence of any measurable pericardial fluid.
Apply it
A rapidly developing procedural effusion is accompanied by circulatory deterioration. You prepare the pericardial drainage equipment requested by the team and recognize that the purpose is to relieve filling constraint, rather than remove blood from within a chamber.
Common pitfall: Do not interpret every effusion as requiring the same intervention. Fluid location and physiological effect matter, and pleural drainage does not relieve a pericardial pressure constraint.
56.What happens to the native valve during TAVR?
Transcatheter aortic valve replacement places a prosthetic valve within the diseased native aortic valve rather than routinely removing that valve surgically. The prosthesis assumes the valve's flow-control function after deployment. TAVR and TAVI name the same general transcatheter treatment approach. Distinguish replacement from balloon valvuloplasty, which expands an existing valve without leaving a replacement valve in place. Understanding the mechanism does not establish universal eligibility: patient anatomy, clinical condition, and the treating team's assessment determine procedural suitability.
Apply it
A patient asks whether the old aortic valve will be cut out during the planned catheter procedure. You explain that the transcatheter prosthesis is placed within the native valve and distinguishes the intervention from an operation that removes it.
Common pitfall: Do not describe TAVR as simple balloon dilation or assume all patients with aortic stenosis are candidates. Device deployment mechanics and patient-selection criteria are separate questions.
57.How does transseptal access reach the mitral valve?
For the transcatheter edge-to-edge mitral repair system described in the FDA reference, venous access leads to the right atrium, followed by transseptal passage into the left atrium. The delivery system is then directed toward the mitral valve from the atrial side. This route differs from advancing a device retrograde through an artery and across the aortic valve. Knowing the chamber sequence helps explain why imaging of septal crossing and left atrial positioning is integral to preparation and guidance.
Apply it
You prepare a transcatheter mitral clip case and trace the planned route from femoral vein to right atrium, across the atrial septum, and into the left atrium. This clarifies why arterial aortic-valve crossing equipment is not the defining access pathway.
Common pitfall: Do not assume every left-sided heart intervention uses arterial access. The specified mitral repair route reaches the left atrium through venous and transseptal access.
58.How does edge-to-edge mitral repair reduce regurgitation?
A mitral edge-to-edge repair device grasps and approximates portions of the mitral leaflets to improve coaptation and reduce backward leakage. It repairs the native valve rather than replacing it with a complete prosthetic valve. The result must balance reduced regurgitation against unrestricted enough forward flow, since excessive narrowing is an important boundary. Imaging assesses leaflet interaction and the final valve result. The historical FDA document supports the device mechanics; its particular study population should not be treated as universal current eligibility.
Apply it
After leaflet approximation, the team reviews both the residual regurgitant jet and forward-flow findings. You recognize why a reduction in leakage alone is insufficient to describe success if the repaired valve has become excessively restrictive to inflow.
Common pitfall: Do not describe the clip as a valve replacement or judge the result only by reduced leakage. Leaflet capture and preservation of adequate forward flow both matter.
59.Why does left atrial appendage closure address stroke risk?
The left atrial appendage is a pouch where blood can stagnate during atrial fibrillation, allowing thrombus to form. Closing its opening separates that potential embolic source from the circulating blood pathway. The objective is stroke-risk reduction through exclusion of the appendage, not electrical elimination of atrial fibrillation. This distinction matters when explaining expected results and follow-up. Do not infer an immediate or universal medication change from the mechanical procedure; antithrombotic management depends on the patient's prescribed plan and device-related follow-up.
Apply it
A patient scheduled for appendage closure expects the device to restore a regular rhythm. You explain that the procedure targets a potential source of embolic clot, while rhythm control and the postprocedure medication plan are separate aspects of care.
Common pitfall: Do not equate appendage exclusion with AF ablation or automatic cessation of anticoagulation. A mechanical stroke-prevention strategy does not itself establish every subsequent treatment decision.
60.How do PFO, septal defects, and appendage targets differ?
A patent foramen ovale is a persistent flap-like passage between atrial septal components that normally close after birth; it is not the same anatomy as an atrial septal defect, in which septal tissue is deficient. A ventricular septal defect is an opening between the ventricles. These distinctions are described in the AHA's [Patent Foramen Ovale reference](https://www.heart.org/en/health-topics/congenital-heart-defects/about-congenital-heart-defects/patent-foramen-ovale-pfo). Septal closure targets an abnormal interchamber communication. Left atrial appendage closure instead excludes a pouch connected to the left atrium. Target anatomy determines the intended device relationship and imaging assessment; an identified communication does not automatically require closure.
Apply it
A structural procedure request identifies a ventricular septal defect. You locate the target between the ventricles rather than at the atrial septum or left atrial appendage. For a PFO case, you distinguish the persistent flap passage from missing atrial septal tissue.
Common pitfall: Do not use PFO and ASD interchangeably or confuse an interchamber opening with an atrial pouch. Similar closure terminology does not establish identical anatomy, physiology, or treatment indications.
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Allocate study effort using the scored counts: 40 Patient Care, 20 Image Production, and 85 Procedures; retain both diagnostic/electrophysiology and interventional coverage.
- Practise contrast-event classification using symptoms, heart-rate pattern, airway involvement, progression, and prior reaction details.
- Pair every monitoring value with its physiological meaning: oxygenation versus ventilation, electrical rhythm versus perfusion, and displayed pressure versus effective flow. Connect pulselessness to immediate resuscitation.
- Use units in every calculation, especially Fick oxygen content in mL/dL, cardiac output in L/min, stroke volume in mL/beat, and valve area in cm².
- Connect radiation settings to a specific imaging task, then distinguish fluoroscopy time, cumulative reference air kerma in Gy or mGy, and kerma-area product in Gy·cm².
- Compare devices by target, access route, energy or flow mechanism, imaging requirements, and characteristic complications.
- Use the full official outline to study additional topics, including thermodilution, detailed Gorlin and shunt calculations, pressure-waveform measurement, bypass and peripheral angiography, biopsy, cardioversion, lead extraction, IVC filters, retrieval procedures, valvuloplasty, and right ventricular support.
A practical preparation plan
1. Map the complete CI outline
Build a study checklist from the applicable official content specifications. Mark which topics these 60 concepts address and which require additional reading. Keep eligibility requirements separate from examination content, and verify the applicable outline for your appointment.
2. Master paired distinctions
Explain each contrast pair aloud: allergic-like versus physiologic reaction, ventilation versus oxygenation, capture versus sensing, anatomy versus physiology, expansion versus apposition, and repair versus replacement. Include the observation that distinguishes the alternatives.
3. Calculate with explicit assumptions
Work Fick, stroke-volume, ejection-fraction, and simplified valve-area examples without skipping units. State when inputs must represent the same physiological state. Identify the required gradient and distinguish absolute flow or volume from a percentage or pressure ratio.
4. Walk through procedural mechanisms
For each procedure, trace the access route and target, describe what the device actually does, identify the imaging needed, and name a relevant complication cue. Give special attention to calcium modification, counterpulsation timing, structural valve interventions, and access patency.
5. Use the drills to diagnose reasoning gaps
Complete the 20 questions before reading their explanations. For every error, identify the missed cue and explain why each alternative is less suitable. Revisit the associated concept, then use the flashcard to recall the principle without looking.
6. Return to omitted outline topics
Finish preparation by revisiting the entire official outline, particularly procedures and equipment not represented in this selective guide. Use current primary references for clinical recommendations and distinguish stable device physiology from recommendations that can change.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- ARRT — Cardiac Interventional Radiography
- ARRT — Reference Documents by Discipline
- ARRT — Examination Content Specifications
- ARRT — R.T. Credential Options
- ARRT — Cardiac Interventional Radiography Examination Content Specifications
- ACR Manual on Contrast Media
- ASA — Standards for Basic Anesthetic Monitoring
- CDC — Summary of Recommendations for Intravascular Catheter-Related Infections
- SCAI — Ad Hoc PCI: Take an Intra-Procedural Time-Out
- SCAI — Quality Documentation in the Cath Lab: Scope for Improvement
- ESC — Cardiac Tamponade: A Clinical Challenge
- IAEA — Radiation Protection of Patients During Interventional Cardiology
- IAEA — Radiation Protection and Safety in Medical Uses of Ionizing Radiation, SSG-46
- Cathcart et al. — Comparison of Cardiac Output Determined by the Ballistocardiograph and by the Direct Fick Method, 1953
- ACC — FFR/iFR: Are the Published Cutoffs Applicable in Athletes?
- AHA — Surgical Procedures for Atrial Fibrillation
- AHA — Ablation for Arrhythmias
- SCAI — Radial Artery Occlusion After Transradial Cardiac Catheterization
- SCAI — Expert Consensus Statement on Management of In-Stent Restenosis and Stent Thrombosis
- SCAI — Expert Consensus on Management of Calcified Coronary Lesions Requiring Intervention
- SCAI Expert Consensus Statement on the Management of Calcified Coronary Lesions — SOLACI-hosted full text
- 2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on Percutaneous Mechanical Circulatory Support
- AHA — What Is TAVR? (TAVI)
- FDA — MitraClip Summary of Safety and Effectiveness Data
- AHA — Nonsurgical Procedures for Atrial Fibrillation
- FDA — Sharps Disposal Containers in Health Care Facilities
- postprimary-eligibility-pathway-handbook.pdf
- State Licensing - ARRT
- The value of echocardiography in aortic valve disease: an in-depth analysis
- WFTF-Chamber-Quantification-Summary-Doc-Final-July-18.pdf
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.